The COVID-19 pandemic forced a number of changes, many of which will remain in place long after it subsides. One important but under-recognized shift could be in the field of clinical diagnostics.

ITHACA, N.Y.--(BUSINESS WIRE)--Rheonix Inc., a manufacturer of a highly advanced microfluidic molecular testing platform, announced the opening of Rheonix Laboratories LLC, a CLIA-certified clinical ...

The partnership expands BioIQ’s fully integrated healthcare services to include Biomeme’s on-site testing platform to provide accurate, real-time RT-PCR COVID-19 test results with centralized access ...

US researchers have developed an innovative smartphone-based kit that can test saliva samples for the presence of SARS-CoV-2 and influenza viruses. Early studies have found the cheap system is as ...